Skip to main content
. 2018 Nov 21;22:319. doi: 10.1186/s13054-018-2247-y

Fig. 3.

Fig. 3

Colistin, piperacillin-tazobactam, and meropenem consumption (defined daily dose/100 bed days) before and after intervention in the intensive care unit (left panel) and in the medical and surgical departments (right panel). *p < 0.05 for comparison with preintervention period